2-26470685-CCTTCTT-CCTTCTTCTT
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_194248.3(OTOF):c.3928_3930dupAAG(p.Lys1310dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000142 in 1,609,576 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Genomes: 𝑓 0.000085 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00015 ( 0 hom. )
Consequence
OTOF
NM_194248.3 conservative_inframe_insertion
NM_194248.3 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.253
Genes affected
OTOF (HGNC:8515): (otoferlin) Mutations in this gene are a cause of neurosensory nonsyndromic recessive deafness, DFNB9. The short form of the encoded protein has 3 C2 domains, a single carboxy-terminal transmembrane domain found also in the C. elegans spermatogenesis factor FER-1 and human dysferlin, while the long form has 6 C2 domains. The homology suggests that this protein may be involved in vesicle membrane fusion. Several transcript variants encoding multiple isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTOF | NM_194248.3 | c.3928_3930dupAAG | p.Lys1310dup | conservative_inframe_insertion | 32/47 | ENST00000272371.7 | NP_919224.1 | |
OTOF | NM_194323.3 | c.1627_1629dupAAG | p.Lys543dup | conservative_inframe_insertion | 15/29 | ENST00000339598.8 | NP_919304.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTOF | ENST00000272371.7 | c.3928_3930dupAAG | p.Lys1310dup | conservative_inframe_insertion | 32/47 | 1 | NM_194248.3 | ENSP00000272371.2 | ||
OTOF | ENST00000339598.8 | c.1627_1629dupAAG | p.Lys543dup | conservative_inframe_insertion | 15/29 | 1 | NM_194323.3 | ENSP00000344521.3 |
Frequencies
GnomAD3 genomes AF: 0.0000855 AC: 13AN: 151970Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
13
AN:
151970
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000189 AC: 47AN: 248192Hom.: 0 AF XY: 0.000164 AC XY: 22AN XY: 134272
GnomAD3 exomes
AF:
AC:
47
AN:
248192
Hom.:
AF XY:
AC XY:
22
AN XY:
134272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000148 AC: 215AN: 1457492Hom.: 0 Cov.: 33 AF XY: 0.000143 AC XY: 104AN XY: 725250
GnomAD4 exome
AF:
AC:
215
AN:
1457492
Hom.:
Cov.:
33
AF XY:
AC XY:
104
AN XY:
725250
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000855 AC: 13AN: 152084Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74336
GnomAD4 genome
AF:
AC:
13
AN:
152084
Hom.:
Cov.:
33
AF XY:
AC XY:
4
AN XY:
74336
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 19, 2022 | This variant, c.3928_3930dup, results in the insertion of 1 amino acid(s) of the OTOF protein (p.Lys1310dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs768338261, gnomAD 0.08%). This variant has been observed in individual(s) with clinical features of OTOF-related conditions (PMID: 25326637). ClinVar contains an entry for this variant (Variation ID: 229079). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jul 01, 2024 | OTOF: PM4:Supporting - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 15, 2022 | Identified with a second OTOF variant in unrelated patients with hearing loss in published literature, however, information regarding presence or absence of auditory neuropathy was not provided (Lee et al., 2014; Liu et al., 2022); In-frame insertion of one amino acid in a repetitive region with no known function; This variant is associated with the following publications: (PMID: 34426522, 35114279, 25326637) - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 22, 2016 | The p.Lys1310dup variant in OTOF has been previously reported in one individual with hearing loss and multiple congenital anomalies who was compound heterozygou s for a second likely pathogenic variant in OTOF (Lee 2014). This variant has a lso been identified in 6/8612 of East Asian chromosomes and 8/16414 South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs768338261). Although this variant has been seen in the general po pulation, its frequency is not high enough to rule out a pathogenic role. This v ariant results in an in-frame insertion of one lysine (Lys) residue in a lysine tract and does not alter the amino acid reading frame. It is unclear if this ins ertion will impact the protein. In summary, the clinical significance of the p.L ys1310dup variant is uncertain. - |
Autosomal recessive nonsyndromic hearing loss 9 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Apr 28, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at